ArticleEuropean urology open science2024
First Impressions of the New da Vinci 5 Robotic Platform and Experience in Performing Robot-assisted Radical Prostatectomy.
Article in European urology open science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A systematic review of global experiences with Medtronic's Hugo™ robotic system for robot-assisted partial nephrectomy.Journal of robotic surgery · 2025Pooled it
- Initial experience with the Saroa surgical system for early-stage lung cancer: a comparative study with the da Vinci surgical system.Surgery today · 2026Article
- Prevalence of Work-Related Pain or Discomfort Among Urologists in the State of Florida: Results From the Florida Urologic Society Task Force on Ergonomic Challenges Experienced by Its Members.JMIR human factors · 2026Article
- Perioperative outcomes comparing the DaVinci 5 with DaVinci Xi in patients undergoing robotic-assisted radical prostatectomy.Prostate cancer and prostatic diseases · 2026Article
- Enhanced surgical efficiency with the next-generation da Vinci 5 system compared with da Vinci Xi: a retrospective cohort study in total laparoscopic hysterectomy.Journal of robotic surgery · 2026Article
- Qualitative perspectives of early surgeon users on the value of the daVinci 5 surgical system.Journal of robotic surgery · 2026Article
- Robotic-Assisted Surgery for Colorectal Cancer Treatment in 2026: An Updated Narrative Review.Journal of clinical medicine · 2026Review
- Laparoscopic Colorectal Surgery in the Era of Robotics: Evolution, Eclipse, or Equilibrium?Annals of gastroenterological surgery · 2026Review
- Early Postoperative Outcomes with the ToumaiCancers · 2026Article
- Towards measuring the challenge: a narrative review on existing concepts and parallels for surgical struggle.Surgical endoscopy · 2026Review
- Article
- Endoscopic Femoropopliteal Bypass Surgery Without Groin Incision: A Feasibility Study on Cadavers with the Da Vinci Single Port System.EJVES vascular forum · 2026Article
- Initial clinical experience with the da Vinci 5 in transoral robotic surgery.Journal of robotic surgery · 2025Article
- Comparing the Technological and Intraoperative Performances of Da Vinci xi and DaVinci 5 Robotic Platforms in Patients Undergoing Robotic-Assisted Radical Prostatectomy.International braz j urol : official journal of the Brazilian Society of UrologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Over the past two decades, robotic surgery has seen substantial advances, with significant growth in novel platforms, particularly since 2019. As a high-volume center experienced with various robotic systems, we share our initial impressions of the new da Vinci 5 platform for robot-assisted radical prostatectomy. Key improvements include enhanced console ergonomics, more precise operative imaging, and the integration of smart commands for streamlined surgical control. Notably, force feedback instruments offer the potential for reduced tissue trauma, although further studies are needed to evaluate long-term outcomes and cost effectiveness. Our early experiences suggest that surgeons familiar with previous da Vinci models, particularly the Xi platform, will find the transition to the da Vinci 5 seamless, with minimal learning curve adjustments. Using propensity score matching, we compared perioperative outcomes for 50 da Vinci 5 RARP procedures (performed after the learning curve) with 150 da Vinci Xi cases. In our experience, optimal performance and perioperative outcomes were obtained with both models. Further studies are needed to identify any clinically significant advantages of one platform over the other. Patient summary: We compared outcomes for patients undergoing removal of the prostate using two different surgical robots (da Vinci Xi and da Vinci 5). Optimal operative outcomes were obtained with both robots, but further studies are needed to evaluate whether one robot is clinically superior to the other.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.